Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod-Reference-Cited by-同舟云学术

Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod

Published:2023-11-01 Issue: Volume: Page:
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Jeantin Lina,Shor Natalia,Pallix-Guyot Maud,Roos-Weil Damien,Bellanger Agnès,Le Garff-Tavernier Magali,Papeix Caroline,Weiss Nicolas,Pourcher Valérie^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

https://link.springer.com/content/pdf/10.1007/s00415-023-12055-9.pdf

Reference15 articles.

1. Kleinschmidt-DeMasters BK (2005) Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis. N Engl J Med 353:369

2. Brinkmann V, Davis MD, Heise CE et al (2002) The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors. J Biol Chem 277:21453–21457. https://doi.org/10.1074/jbc.C200176200

3. Berger JR, Cree BA, Greenberg B et al (2018) Progressive multifocal leukoencephalopathy after fingolimod treatment. Neurology 90:e1815–e1821. https://doi.org/10.1212/WNL.0000000000005529

4. Sriwastava S, Chaudhary D, Srivastava S et al (2022) Progressive multifocal leukoencephalopathy and sphingosine 1-phosphate receptor modulators used in multiple sclerosis: an updated review of literature. J Neurol 269:1678–1687. https://doi.org/10.1007/s00415-021-10910-1

5. Cortese I, Muranski P, Enose-Akahata Y et al (2019) Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy. N Engl J Med 380:1597–1605. https://doi.org/10.1056/NEJMoa1815039

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fingolimod;Reactions Weekly;2024-08-31